Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets, , , , , , , , , and 18 other author(s). Acta Neuropathol, 131 (6): 903-910 (June 2016)N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma, , , , , , , , , and 9 other author(s). Neuro Oncol, 21 (1): 95-105 (January 2019)Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge, , , , , , , , , and 5 other author(s). Nat Rev Cancer, 14 (2): 92-107 (February 2014)N2M2 (NOA20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma, , , , , , , , , and 9 other author(s). Neuro Oncol, (October 2018)Telomere dysfunction and chromothripsis, , , , , , , , , and 15 other author(s). Int J Cancer, 138 (12): 2905-2914 (June 2016)Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations, , , , , , , , , and 46 other author(s). Acta Neuropathol, (March 2018)ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma, , , , , , , , , and 9 other author(s). Acta Neuropathol, 129 (1): 133-146 (January 2015)Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, , , , , , , , , and 17 other author(s). Acta Neuropathol, 130 (3): 407-417 (September 2015)Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain, , , , , , , , , and 17 other author(s). Acta Neuropathol, (May 2015)Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study, , , , , , , , , and 11 other author(s). Neuro Oncol, 20 (6): 826-837 (May 2018)